CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds

• Clayton, Dubilier & Rice named Giovanni Caforio an operating advisor to its funds, focusing on healthcare investment sourcing and evaluation.
• Caforio is chair of Novartis, leading the board since 2025.
• He previously spent most of his career at Bristol Myers Squibb, serving as CEO from May 2015 until stepping down in 2023.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clayton, Dubilier & Rice LLC published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.